Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$727K Buy
242,285
+145,291
+150% +$562K 0.01% 1701
2025
Q4
$590K Buy
96,994
+69,161
+248% +$629K 0.02% 1458
2025
Q3
$306K Buy
27,833
+8,800
+46% +$77.9K 0.02% 1486
2025
Q2
$133K Buy
+19,033
New +$116K 0.01% 1820

Other funds holding XGN

XTX Topco's XGN Position: Q1 2026 in Review

XTX Topco increased its Exagen (XGN) stake by 150% in Q1 2026, buying an estimated $562K and bringing the position to 242,285 shares worth $727K. The position accounts for 0.01% of the portfolio, ranked #1701.

XTX Topco first reported a position in XGN in Q2 2025 and has held it in 4 quarters since. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • XTX Topco held 242,285 shares of Exagen worth $727K as of Q1 2026.
  • XTX Topco bought 145,291 Exagen shares in Q1 2026, an estimated $562K.
  • Exagen made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1701 holding.
  • XTX Topco first reported a position in Exagen in Q2 2025 and has held it in 4 quarters since.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.